Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IPN-01194 by Ipsen for Metastatic Melanoma: Likelihood of Approval
IPN-01194 is under clinical development by Ipsen and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...
IPN-01194 by Ipsen for Solid Tumor: Likelihood of Approval
IPN-01194 is under clinical development by Ipsen and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
IPN-01194 by Ipsen for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
IPN-01194 is under clinical development by Ipsen and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...
IPN-01194 by Ipsen for Metastatic Colorectal Cancer: Likelihood of Approval
IPN-01194 is under clinical development by Ipsen and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase...
IPN-01194 by Ipsen for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
IPN-01194 is under clinical development by Ipsen and currently in Phase II for Head And Neck Squamous Cell Carcinoma (HNSC)....